NCT04656964View on ClinicalTrials.gov

Comparison Between Remimazolam Tosilate and Midazolam in Elderly Patients Undergoing Gastrointestinal Endoscopy

NACompletedINTERVENTIONAL

Enrollment

353

Participants

Timeline

Start Date

April 1, 2021

Primary Completion Date

December 31, 2022

Study Completion Date

December 31, 2022

Conditions

Elderly PatientsGastrointestinal EndoscopyMidazolamRemimazolam

Interventions

DRUG

remimazolam tosilate group

Patients received an initial dose of 0.2mg/kg of remimazolam tosilate(plus repeated 2.5 mg top-ups doses to a total of up to 12.5mg within 15 minutes).

DRUG

Midazolam group

Patients received an initial dose of 0.03mg/kg of midazolam(One additional dose of 0.015 mg / kg midazolam was allowed).

Trial Locations (1)

100049

Peking University People's Hospital, Beijing

All Listed Sponsors

collaborator

Emergency General Hospital

OTHER

collaborator

Fenyang Hospital Affiliated to Shanxi Medical University

UNKNOWN

lead

Peking University People's Hospital

OTHER

NCT04656964 - Comparison Between Remimazolam Tosilate and Midazolam in Elderly Patients Undergoing Gastrointestinal Endoscopy | Biotech Hunter | Biotech Hunter